I was alerted to the ECTE price and any investor with long term goals will jump at this offering. Bringing product to market costs money! EU roll out which will no doubt be followed by FDA approval costs money. He obviously did what he could to get funding and it failed. I sold out of another position just to get in here. I will buy in and I won't look again till 2014 and I "guarantee" a healthy return on my initial investment. Go Long, be patient and consider yourselves fortunate to get in at these levels.